Page 3 - Aurinia Pharmaceutical News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Aurinia pharmaceutical. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Aurinia Pharmaceutical Today - Breaking & Trending Today

Institutions own 42% of Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) shares but individual investors control 56% of the company

Key Insights Significant control over Aurinia Pharmaceuticals by individual investors implies that the general public. ....

Co Ltd , Aurinia Pharmaceuticals , Aurinia Pharmaceuticals Inc , Blackrock Inc , Armistice Capital , Institutional Ownership Tell Us About Aurinia Pharmaceuticals , Aurinia Pharmaceutical , Individual Investors , Institutional Investors ,

Cantor Fitzgerald Comments on Aurinia Pharmaceuticals Inc.'s FY2024 Earnings (NASDAQ:AUPH)

Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH – Free Report) (TSE:AUP) – Equities research analysts at Cantor Fitzgerald issued their FY2024 earnings estimates for shares of Aurinia Pharmaceuticals in a report issued on Tuesday, July 11th. Cantor Fitzgerald analyst O. Brayer forecasts that the biotechnology company will post earnings of ($0.39) per share for the year. The consensus […] ....

Nova Scotia , United States , Davidrw Jayne , Aurinia Pharmaceuticals , Armistice Capital , Aurinia Pharmaceuticals Company Profile , Otsuka Pharmaceutical Co Ltd , Cantor Fitzgerald , Institutional Trading Of Aurinia Pharmaceuticals , Securities Exchange Commission , Aurinia Pharmaceuticals Inc , Insider Activity At Aurinia Pharmaceuticals , Royal Bank , Blackrock Inc , Aurinia Pharmaceuticals Stock Down , News Ratings For Aurinia Pharmaceuticals Daily , Bellevue Group , Free Report , Aurinia Pharmaceutical , Get Free Report , Pharmaceuticals Stock Down , Street Corp , Exchange Commission , Pharmaceuticals Inc , Aurinia Pharmaceuticals Daily ,

Financial Review: Bausch Health Companies (NYSE:BHC) vs. Aurinia Pharmaceuticals (NASDAQ:AUPH)

Bausch Health Companies (NYSE:BHC – Free Report) and Aurinia Pharmaceuticals (NASDAQ:AUPH – Free Report) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their profitability, risk, analyst recommendations, earnings, institutional ownership, valuation and dividends. Institutional & Insider Ownership 74.4% of Bausch Health Companies […] ....

United States , News Ratings For Bausch Health Companies Daily , Bausch Health Companies , Solta Medical , Bausch Health Companies Inc , Aurinia Pharmaceuticals , Valeant Pharmaceuticals International Inc , Otsuka Pharmaceutical Co Ltd , Aurinia Pharmaceuticals Inc , Free Report , Health Companies , Given Aurinia Pharmaceutical , Bausch Health , Aurinia Pharmaceutical , Valeant Pharmaceuticals International , Pharmaceuticals Inc , Bausch Health Companies Daily ,

Even With High Proteinuria, Voclosporin Proves Benefit in Lupus Nephritis

An analysis of data from the phase 2 AURA-LV and phase 3 AURORA 1 trials provides new insight into the effects of voclosporin for the treatment of active lupus nephritis in patients with high proteinuria. ....

Emily Littlejohn , Greg Keenan , Aurinia Pharmaceuticals Inc , European Congress , Drug Administration , Cleveland Clinic , Cleveland Clinic Lupus , Odds Ratio , Aurinia Pharmaceuticals , Aurinia Pharmaceutical ,

Renal Biopsy Data Supports Long-Term Voclosporin Use for Lupus Nephritis

Data from an analysis of kidney biopsies from the AURORA 2 trial presented at CCR East 2023 offer new insight into the long-term histological impact of voclosporin use on renal function in patients with lupus nephritis. ....

Samir Parikh , Aurinia Pharmaceuticals Inc , European Renal Association Congress , European Renal Association , Clinical Congress , Drug Administration , Ohio State University Wexner Medical Center , Ohio State University Wexler Medical Center , Clinical Rheumatology , Kidney Biopsies , Trial Evaluating Voclosporin , Aurinia Pharmaceutical , Aurinia Pharmaceuticals , Published January , Renal Association , Published May ,